WHO clears Plifzer for emergency use authorisation

The WHO announced Plifzer-BioNtech coronavirus vaccine has cleared the emergency use authorisation. The vaccine has already received clearance in the United States, Britain, the European Union, Bahrain and many other countries. Weak economies will rely on WHO to vet the vaccination shots. The BioNTech-Pfizer vaccine has to be stored at ultra-frozen temperatures and hence it’s difficult for developing countries where the required freezers and electricity may not be available.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Privacy & Cookies Policy